Literature DB >> 17894926

Myofascial dysfunction associated with chronic pelvic floor pain: management strategies.

Arun K Srinivasan1, Jonathan D Kaye, Robert Moldwin.   

Abstract

Myofascial pain as a cause of chronic pelvic pain with or without pelvic organ pathology is well-documented in the literature. Causes of this pain are multifactorial, including specific pelvic organ pathologies, neuromuscular disorders, and psychologic causes. Management of this myofascial component of chronic pelvic pain involves a multidisciplinary approach including physicians, physical therapists, neurologists, and psychiatrists. Treatment strategies, including behavioral management, medications, physical therapy, trigger point injections, neuromodulation, botulinum toxin injection, and other lesser known treatment modalities, are discussed in detail in this article.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17894926     DOI: 10.1007/s11916-007-0218-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  25 in total

1.  Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors:  R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal:  J Urol       Date:  1999-08       Impact factor: 7.450

2.  Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?

Authors:  D h Zermann; M Ishigooka; J Schubert; R A Schmidt
Journal:  Eur Urol       Date:  2000-10       Impact factor: 20.096

3.  COCCYGODYNIA: CAUSE AND TREATMENT.

Authors:  G H THIELE
Journal:  Dis Colon Rectum       Date:  1963 Nov-Dec       Impact factor: 4.585

4.  Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.

Authors:  Jason A Abbott; Sherin K Jarvis; Stephen D Lyons; Angus Thomson; Thierry G Vancaille
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

Review 5.  Multidisciplinary approach to chronic pelvic pain.

Authors:  A Milburn; R C Reiter; A T Rhomberg
Journal:  Obstet Gynecol Clin North Am       Date:  1993-12       Impact factor: 2.844

6.  Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome.

Authors:  J Q Clemens; R B Nadler; A J Schaeffer; J Belani; J Albaugh; W Bushman
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

7.  Irritable bowel syndrome in the gynecological clinic. Survey of 798 new referrals.

Authors:  A Prior; K Wilson; P J Whorwell; E B Faragher
Journal:  Dig Dis Sci       Date:  1989-12       Impact factor: 3.199

8.  Neurourological insights into the etiology of genitourinary pain in men.

Authors:  D H Zermann; M Ishigooka; R Doggweiler; R A Schmidt
Journal:  J Urol       Date:  1999-03       Impact factor: 7.450

9.  Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.

Authors:  Sherif Aboseif; Kirk Tamaddon; Stuart Chalfin; Sheldon Freedman; John Kaptein
Journal:  Urology       Date:  2002-07       Impact factor: 2.649

Review 10.  Etiology: where does prostatitis stop and interstitial cystitis begin?

Authors:  Evan R Eisenberg; Robert M Moldwin
Journal:  World J Urol       Date:  2003-05-28       Impact factor: 4.226

View more
  11 in total

1.  Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy.

Authors:  Robert M Moldwin; Jennifer Yonaitis Fariello
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

2.  A pilot randomized trial of levator injections versus physical therapy for treatment of pelvic floor myalgia and sexual pain.

Authors:  Dani Zoorob; Mary South; Mickey Karram; Julie Sroga; Rose Maxwell; Aparna Shah; James Whiteside
Journal:  Int Urogynecol J       Date:  2014-12-20       Impact factor: 2.894

3.  Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial.

Authors:  Catrina C Crisp; Christine M Vaccaro; M Victoria Estanol; Susan H Oakley; Steven D Kleeman; Angela N Fellner; Rachel N Pauls
Journal:  Int Urogynecol J       Date:  2013-05-17       Impact factor: 2.894

4.  Botulinum toxin type A (BOTOX) for refractory myofascial pelvic pain.

Authors:  Amos Adelowo; Michele R Hacker; Alex Shapiro; Anna Merport Modest; Eman Elkadry
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 Sep-Oct       Impact factor: 2.091

5.  Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction.

Authors:  Matthew J Rogalski; Susan Kellogg-Spadt; Amy R Hoffmann; Jennifer Y Fariello; Kristene E Whitmore
Journal:  Int Urogynecol J       Date:  2010-01-12       Impact factor: 2.894

6.  A randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A trigger point injections for myofascial pelvic pain.

Authors:  Sybil G Dessie; Emily Von Bargen; Michele R Hacker; Miriam J Haviland; Eman Elkadry
Journal:  Am J Obstet Gynecol       Date:  2019-06-27       Impact factor: 10.693

7.  Referred pain patterns provoked on intra-pelvic structures among women with and without chronic pelvic pain: a descriptive study.

Authors:  Thomas Torstensson; Stephen Butler; Anne Lindgren; Magnus Peterson; Margaretha Eriksson; Per Kristiansson
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Botox combined with myofascial release physical therapy as a treatment for myofascial pelvic pain.

Authors:  Gabriela E Halder; Lauren Scott; Allison Wyman; Nelsi Mora; Branko Miladinovic; Renee Bassaly; Lennox Hoyte
Journal:  Investig Clin Urol       Date:  2017-02-01

Review 9.  Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource.

Authors:  Bary Berghmans
Journal:  Int Urogynecol J       Date:  2018-01-09       Impact factor: 2.894

Review 10.  Therapeutic Approaches of Botulinum Toxin in Gynecology.

Authors:  Marius Alexandru Moga; Oana Gabriela Dimienescu; Andreea Bălan; Ioan Scârneciu; Barna Barabaș; Liana Pleș
Journal:  Toxins (Basel)       Date:  2018-04-21       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.